by Jordana Choucair | Nov 30, 2022 | Life Sciences
Eisai Co. Ltd. and Biogen Inc.’s Alzheimer drug lecanemab slowed patients’ mental decline by 27 percent over 18 months, according to a trial presented at the Clinical Trials on Alzheimer’s Disease conference. However, more than one in five people...
by Jordana Choucair | Nov 30, 2022 | Opioid/Substance Use Disorders
New data published Wednesday by the National Center for Health Statistics show that deaths from drug and alcohol use are rising among America’s seniors. According to the data, drug overdose deaths more than tripled among people aged 65 and older during the past two...
by Jordana Choucair | Nov 30, 2022 | M&A
Horizon Therapeutics PLC is hearing buyout offers from pharmaceutical companies Amgen Inc., Johnson & Johnson’s Janssen Global Services LLC, and Sanofi. Horizon, which makes medicines for rare and immune diseases, had a market value of $18 billion as of...
by Jordana Choucair | Nov 30, 2022 | Mental Health
New York City Mayor Eric Adams unveiled a new plan to remove people with severe, untreated mental illness from city streets and subways. Under the plan, New York City agencies – such as the New York Police Department and New York City Fire Department – and emergency...
by Jordana Choucair | Nov 30, 2022 | Providers
The Centers for Medicare & Medicaid Services (CMS) published a memo reminding hospitals of their responsibility to protect patients and health care workers from physical violence in the workplace. The memo said hospitals should be able to demonstrate their...
Recent Comments